Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 TRANQUILITY‑2 Trial in Dry Eye Disease and Intends to Submit New Drug Application for Symptoms and Three Sign Endpoints of Dry Eye Disease | BioSpace
Tranquility Beach | Brigadoon Vacation Rentals | Washington | Book Direct | Family Rental | Business trip | Strait of Juan de Fuca | Save Money | Discounted Rates | Beach Access